Related Experiment Video
Updated: May 3, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
[Screening of urinary biomarkers in patients with type 2 diabetes mellitus]
Han Fu1, Xiaoli Liu1, Wei Yu1
1MOE Key Lab of Environment and Health, Institute of Environmental Medicine, School of Public Health, Tongji Medical College, Huazhong University of Science, Wuhan 430030, China.
Objective:
To screen the biomarkers of the middle-aged type 2 diabetes (T2DM) in urine based on metabolomics.
Methods:
First, both the metabolite profiles of morning urine sample in T2DM and control group were obtained by liquid chromatography-mass spectrometry (LC-MS). Second, an automated compound (feature) extraction algorithm was employed for processing background subtracted single MS data. Then principal component analysis (PCA) and t-Test analysis was followed after preprocessing on the extractive data. Third, identifying the potential biomarkers that show significant difference between the two groups by searching the database online and comparing the results of MS/MS experiments to those available in literature and those standards.
Results:
Three endogenous metabolites, among which tryptophan, kynurenic acid, and shown down-regulation while kynurenine shown up-regulation in T2DM, significantly differentiate between T2DM and control group.
Conclusion:
Tryptophan, kynurenic acid and kynurenine may be considered as the potentail biomarkers related to T2DM.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Urine Studies I: Urinalysis
Type II Diabetes II: Pathophysiology
Diabetic Nephropathy

